>>> US After Hours Summary: EB -24%, NVEE -16%, FIZZ -15%, OKTA -7% ar


After Hours Summary: EB -24%, NVEE -16%, FIZZ -15%, OKTA -7% are lower, while UPLD +9%, COST +5% are higher following earnings/guidance

After Hours Gainers:

Companies trading higher in after hours in reaction to earnings/guidance: CYRX +16.5% (light volume), ERII +13.5%, JYNT +11.4%, UPLD +9.1%, SUPV +8.1%, COST +5%

Companies trading higher in after hours in reaction to news: MDCA +15.5% (attributed to WSJ report that Mark Penn in talks to become CEO with minority stake in the company), ARDX +7.7% (announces peer-reviewed publication of positive phase 3 results of tenapanor for the treatment of hyperphosphatemia), ARQL +3.3% (following today's 67% move higher), ICHR +2.6% (rebounding on light volume; initiated with Buy and $30 tgt at DA Davidson), VSTM +2.5% (announced that three COPIKTRA abstracts were presented), TLRY +1.7% (modestly rebounding after closing 8% lower on the day), TRN +1% (announces new $350 mln share repurchase program; increases quarterly dividend to $0.17/share from $0.13/share), HAIN +0.9% (Engaged Capital increases active stake), TSLA +0.8% (following loan agreement updates), NAV +0.5% (ticking higher ahead of earnings; also signed service partnership agreement with Love's Travel Stops)

After Hours Losers:

Companies trading lower in after hours in reaction to earnings/guidance: EB -24.1%, NVEE -15.6%, TTOO -15.6%, INSY -15.5%, FIZZ -15.2%, OKTA -7%, CWH -6.4%, AOBC -6.3%, CHUY -3.5%, LOCO -2.1% (light volume), MRVL -1.3%,

Companies trading lower in after hours in reaction to news: WTER -13.1% (proposed public offering of common stock), TRVN -9.4% (discloses the FDA said data was not sufficient to support the continuation of FDA's previously granted Breakthrough Therapy designation to oliceridine), PCG -2% (still checking; note that the co previously extended deadline for nomination of Board members to March 8)